Last 29.30
Change Today -0.60 / -2.01%
Volume 298.5K
MDGS On Other Exchanges
Tel Aviv
As of 9:39 AM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

medigus ltd (MDGS) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/23/14 - $67.30
52 Week Low
12/30/14 - $25.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDIGUS LTD (MDGS)

Related News

No related news articles were found.

medigus ltd (MDGS) Related Businessweek News

No Related Businessweek News Found

medigus ltd (MDGS) Details

Medigus Ltd., a medical device company, designs, develops, and sells endoscopic procedures and devices. The company offers Medigus Ultrasonic Surgical Endostapler system, an endoscope device comprising a surgical stapler, miniature camera, and an ultrasound sensor for incisionless treatment of gastroesophageal reflux disease. Medigus Ltd. was founded in 2000 and is headquartered in Omer, Israel.

Founded in 2000

medigus ltd (MDGS) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: 345.0K
Founder and Global Chief Operating Officer
Total Annual Compensation: 7.0K
Chief Financial Officer
Total Annual Compensation: 443.0K
Executive Vice President
Total Annual Compensation: 523.0K
Chief Technology Officer
Total Annual Compensation: 421.0K
Compensation as of Fiscal Year 2013.

medigus ltd (MDGS) Key Developments

Medigus Announces Extension of Exclusive Distribution Agreement with Sinopharm in China

Medigus Ltd. announced an extension of its 2013 agreement with Sinopharm (China National Pharmaceutical Group Corporation) which granted the Chinese pharmaceutical company exclusive rights to distribute the MUSE(TM) system in China. Sinopharm has been granted up to two years from the date of the extension of the agreement to gain all necessary regulatory approvals from the China Food and Drug Administration (CFDA). The agreement extends Sinopharm's exclusivity to distribute the MUSE system from two to four years following receipt of such regulatory approvals, and Sinopharm has also committed to purchasing a minimum of $17.6 million worth of MUSE and related products over the course of four years, from the date of CFDA approval. Medigus will receive an upfront deposit of $350,000 towards initial purchase of MUSE systems, which will be returned by Medigus (less any amounts for products ordered) if the regulatory approval is not achieved during the timeframe specified in the agreement. The agreement also provides Sinopharm with the discretionary right to appoint Golden Grand Medical (Shanghai Golden Grand-Medical Instruments Ltd.), a Chinese company specializing in the distribution of medical devices, as its exclusive sub-distributor in China. Under the agreement, Golden will manage sales and customer service, marketing and training, and recording of clinical trials, following submittal of non-compete clauses and intellectual property protection, and other, similar restrictions, while Sinopharm remains solely responsible towards Medigus under the agreement.

MediGus Ltd., Annual General Meeting, Dec 12, 2014

MediGus Ltd., Annual General Meeting, Dec 12, 2014., at 11:00 Israel Standard Time.

MediGus Ltd. Presents at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum, Nov-20-2014 04:00 PM

MediGus Ltd. Presents at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum, Nov-20-2014 04:00 PM. Venue: The Westin Grand Central, New York, New York, United States. Speakers: Christopher Rowland, Chief Executive Officer and Director.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDGS:IT 29.30 -0.60

MDGS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDGS.
View Industry Companies

Industry Analysis


Industry Average

Valuation MDGS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIGUS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at